Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer
Current Problems in Cancer: Case Reports · 2020
DOI: 10.1016/j.cpccr.2020.100014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Problems in Cancer: Case Reports, 2020. Verfasst von Stephanie Andrews und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Immunotherapy has revolutionized medical oncology by providing durable responses in a number of malignancies. Programmed death-1 inhibitors are rapidly gaining popularity and increased use. They are also associated with a variety of adverse reactions. Although PD-1 inhibitors are generally tolerated relatively well and usually have milder side effects than chemotherapy, the risk remains for immune mediated adverse reactions. Caution should be exercised when re-challenging grade three or four adverse effects with the same agent or a different agent of the same class. The reemergence of a previous toxicity may occur or new toxicity. Immune related adverse events affect the nervous system and effects are generally mild however this case describes an exotic, fatal outcome in a patient with severe enteric neuropathy.
Zitieren
APA
Andrews, S., & Ludlow, S. P. (2020). Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer. Current Problems in Cancer: Case Reports. https://doi.org/10.1016/j.cpccr.2020.100014
Vancouver
Andrews S, Ludlow SP. Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer. Current Problems in Cancer: Case Reports. 2020. doi:10.1016/j.cpccr.2020.100014
BibTeX
@article{Andrews2020,
author = {Andrews, Stephanie and Ludlow, Steven P.},
title = {Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer},
journal = {Current Problems in Cancer: Case Reports},
year = {2020},
doi = {10.1016/j.cpccr.2020.100014}
}
EUVIMED